Workflow
NICE Ltd: A Software Company Trading At A Hardware Valuation
Seeking Alpha· 2025-01-22 13:33
NICE Ltd. (NASDAQ: NICE ) may not be a stock you hear about in the financial news often, but that doesn't mean you should ignore it. NICE offers customer experience [CX] and financial crime & compliance [FCC] solutions. It also offers public safety [PS] solutions, but it's a very minor partI objectively search for undervalued stocks of any size across a wide variety of industries using quantitative methods that I've thoroughly backtested for success. I believe the numbers are more important than the story ( ...
ISRG Likely to Beat Q4 Expectations: How to Play the Stock?
ZACKS· 2025-01-22 13:31
Intuitive Surgical, Inc. (ISRG) is set to report fourth-quarter 2024 earnings on Jan. 23. The Zacks Consensus Estimate for sales and earnings is pegged at $2.41 billion and $1.77 per share, respectively. Earnings per share estimates for ISRG increased 1 cent to $6.67 and $7.66 for 2024 and 2025, respectively, over the past 30 days. Per the preliminary fourth-quarter results announced earlier this month, the company’s top-line is anticipated to increase 25%.Intuitive Surgical’s close peers, namely Thermo Fis ...
Dollar Tree Trading Above 50-Day SMA: Is the Stock Worth Buying?
ZACKS· 2025-01-22 13:31
Dollar Tree, Inc. (DLTR) is trading above its 50-day simple moving average (SMA), signaling a bullish trend. The company is gaining from sales growth across segments, higher traffic trends and market share gains.The 50-day SMA is a key indicator for traders and analysts to identify support and resistance levels. It is considered particularly important as it is the first marker of a stock’s uptrend or downtrend.DLTR Stock Trading Above 50 Day Moving AverageImage Source: Zacks Investment ResearchDLTR has show ...
Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates
ZACKS· 2025-01-22 13:31
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2%. A quarter ago, it was expected that this world's biggest maker of health care products would post earnings of $2.22 per share when it actually produced earnings of $2.42, delivering a surprise of 9.01%.Over the l ...
Kick Off the Jeopardy! Tournament of Champions January 24 on TuneIn
GlobeNewswire· 2025-01-22 13:31
The top three seeded champions square off in an audio-only exhibition game premiering exclusively on TuneInSAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- TuneIn, the world’s leader in live audio, announced today in collaboration with Sony Pictures Television the premiere of the Jeopardy! Tournament of Champions Exhibition Game premiering exclusively on TuneIn for free. TuneIn will host an exhibition game featuring the top three seeded Jeopardy! champions from the past season ahead of their appearances in ...
Rocket Software Introduces Phishing-Resistant Solution for Secure Host Connectivity
GlobeNewswire· 2025-01-22 13:31
New terminal emulator extends multi-factor authentication, single sign-on, and other authentication best practices to support mainframe security and compliance with emerging regulationsWALTHAM, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Software, a global technology leader in modernization software, today announced the launch of Rocket® Secure Host Access, a security-first terminal emulator differentiated in its ability to integrate green screen access with existing identity and access management (IAM) ...
Helport AI and LendSure Mortgage Corp. Partner to Transform Mortgage Industry with AI-Powered Tools
Newsfilter· 2025-01-22 13:31
Helport AI's Platform Integration to Increase Loan Officer Productivity While Reducing Overhead Costs for LendSure and Mortgage Costs for its Borrowers, Aiming to Drive Industry-Wide Transformation SINGAPORE and SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ:HPAI) ( "Helport AI"), an AI technology company serving enterprise clients with intelligent customer communication software, services, and solutions, today announced a new strategic partnership with U.S.-based LendSure Mortgage ...
REEMAG Achieves Major Milestone in Sustainable Magnet Production with Successful Scale-Up of Recycled NdFeB Magnets
GlobeNewswire· 2025-01-22 13:30
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- REEMAG LLC (“REEMAG” or the “Company”), a leader in sustainable rare earth magnet recycling, and a portfolio company of Cove Capital LLC, proudly announces a significant breakthrough in its mission to transform the rare earth magnet industry with low-carbon footprint solutions. The company has successfully scaled its innovative and proprietary carbon-free recycling process from a single NdFeB (neodymium-iron-boron) magnet to handle a quantity approximately 100 tim ...
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
GlobeNewswire· 2025-01-22 13:30
PALM BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The demand for effective pancreatic cancer treatments is and has been undeniably high. The growing number of diagnoses, with the aggressive nature of the disease, fuels the market. This demand is further amplified by rising awareness and a focus on personalized medicine, leading to potentially more targeted and effective therapies. Pancreatic cancer remains a formidable foe, with the American Cancer Society estimating over ...
Global Virology Market is Expected to Reach USD 3,808.9 Million by 2035, Driven by Developments in Antiviral Drugs, Diagnostics, and Vaccines | Future Market Insights, Inc.
GlobeNewswire· 2025-01-22 13:30
The United States virology market is expected to grow at a CAGR of 6.6% from 2025 to 2035, maintaining the largest share in the North American market throughout the forecast period. This growth is primarily driven by increased investments from private organizations and pharmaceutical companies, which are advancing antiviral therapies, vaccines, and diagnostic technologies to address both emerging and established viral threats. Biotech companies, in particular, are highly innovative, focusing on new drug dis ...